Innovent Dosed First Participant in Phase 3 Clinical Study (GLORY-2) of Mazdutide (IBI362) Higher Dose 9 mg in Chinese Adults with Obesity
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameInnovent Biologics, Inc.
-
Registration countryCayman Islands
-
IndustryMiscellaneous Healthcare: Products and Services
-
М/S&P/F
*** /*** /***









